<div id=toc></div>

# Table of Contents

- [q-bio.BM](#q-bio.BM) [Total: 2]
- [q-bio.TO](#q-bio.TO) [Total: 1]
- [physics.bio-ph](#physics.bio-ph) [Total: 1]


<div id='q-bio.BM'></div>

# q-bio.BM [[Back]](#toc)

### [1] [TopoBind: Multi-Modal Prediction of Antibody-Antigen Binding Free Energy via Sequence Embeddings and Structural Topology](https://arxiv.org/abs/2508.19632)
*Ciyuan Yu,Hongzong Li,Jiahao Ma,Shiqin Tang,Ye-Fan Hu,Jian-Dong Huang*

Main category: q-bio.BM

TL;DR: 提出了一种结合序列嵌入和多种拓扑特征的新框架，显著提高了抗体与抗原结合自由能的预测准确性。


<details>
  <summary>Details</summary>
Motivation: 现有方法仅依赖序列嵌入或难以捕捉复杂结构关系，限制了预测性能。

Method: 整合预训练蛋白质语言模型（ESM-2）的序列表示与拓扑特征（如接触图、距离图统计等），并通过跨注意力机制融合这些模态。

Result: 模型在结合自由能预测中超越现有序列和结构模型，达到最先进水平。

Conclusion: 综合多模态特征能有效提升抗体-抗原结合自由能预测的准确性。

Abstract: Predicting the binding free energy between antibodies and antigens is a key
challenge in structure-aware biomolecular modeling, with direct implications
for antibody design. Most existing methods either rely solely on sequence
embeddings or struggle to capture complex structural relationships, thus
limiting predictive performance. In this work, we present a novel framework
that integrates sequence-based representations from pre-trained protein
language models (ESM-2) with a set of topological features. Specifically, we
extract contact map metrics reflecting residue-level connectivity, interface
geometry descriptors characterizing cross-chain interactions, distance map
statistics quantifying spatial organization, and persistent homology invariants
that systematically capture the emergence and persistence of multi-scale
topological structures - such as connected components, cycles, and cavities -
within individual proteins and across the antibody-antigen interface. By
leveraging a cross-attention mechanism to fuse these diverse modalities, our
model effectively encodes both global and local structural organization,
thereby substantially enhancing the prediction of binding free energy.
Extensive experiments demonstrate that our model consistently outperforms
sequence-only and conventional structural models, achieving state-of-the-art
accuracy in binding free energy prediction.

</details>


### [2] [Modal Geometry Governs Proteoform Dynamics](https://arxiv.org/abs/2508.20004)
*James N. Cobley*

Main category: q-bio.BM

TL;DR: 文章提出Modal Geometric Field (MGF)理论，通过四个公理解释蛋白质变体如何通过模态几何动态塑造其未来。理论将能量、熵和曲率统一，揭示了蛋白质动态的路径依赖和分形自相似性。


<details>
  <summary>Details</summary>
Motivation: 探索蛋白质变体如何通过动态模态几何塑造其未来，理解蛋白质行为的根本原理。

Method: 结合实数和抽象的蛋白质变体转变，通过四个公理（三个不变公理和一个可变公理），将广义相对论中的曲率引入模态流形。

Result: 理论揭示了曲率如何动态影响蛋白质行为，导致路径依赖、分形自相似性以及秩序与混沌的交替。

Conclusion: MGF理论为蛋白质动态提供了一个尺度不变和普适的框架，揭示了模态几何对其行为的核心作用。

Abstract: A central mystery is how a specific proteoform, a distinct molecular variant
of a protein, dynamically shapes its own future by evolving into new modes that
exist only in potential until realised. Here, Modal Geometric Field (MGF)
Theory couples real and abstract proteoform transitions through four axioms.
Axioms one-three (invariant) dictate that only first-order transitions occur on
the discrete, volume invariant, non symplectic modal manifold. Axiom four
(mutable) functorially projects the general relativity derived curvature of an
instantiated proteoform into this modal manifold, coupling what is real to what
is abstract. Curvature, conserved per a discrete Noether theorem, actively
shapes proteoform dynamics. Because curvature distribution renders activation
energy relative, curvature-derived barriers are mutable, in direct analogy to
general relativity. Entropy then emerges inevitably from curvature transport.
This unification of energy, entropy, and curvature yields hysteresis, path
dependence, fractal self similarity, and trajectories that oscillate between
order and chaos. As a scale invariant and universal framework, MGF Theory
reveals how modal geometry governs proteoform dynamics.

</details>


<div id='q-bio.TO'></div>

# q-bio.TO [[Back]](#toc)

### [3] [A Multi-Layered Framework for Modeling Human Biology: From Basic AI Agents to a Full-Body AI Agent](https://arxiv.org/abs/2508.19800)
*Aoqi Wang,Jiajia Liu,Jianguo Wen,Yangyang Luo,Zhiwei Fan,Liren Yang,Xi Hu,Ruihan Luo,Yankai Yu,Sophia Li,Weiling Zhao,Xiaobo Zhou*

Main category: q-bio.TO

TL;DR: Full-Body AI Agent是一个多层次的AI系统，旨在模拟、分析和优化人体动态生物过程，涵盖分子到全身系统水平，通过整合计算模型和实验平台，推动疾病机制理解、治疗开发和个性化医疗。


<details>
  <summary>Details</summary>
Motivation: 该系统的动机在于通过跨层次整合，揭示分子变化对全身生理和病理过程的影响，从而解决复杂的生物医学挑战。

Method: 系统结合计算模型、机器学习工具和实验平台，开发了两个专门应用：转移AI代理（多尺度转移评分系统）和药物AI代理（系统级药物开发范式）。

Result: 这两个代理展示了Full-Body AI Agent在多层次集成和跨尺度推理方面的潜力，能够在更大范围内预测药物效果和毒性。

Conclusion: Full-Body AI Agent通过多生物层次的整合，为复杂生物医学问题提供了新的解决方案，推动了精准医疗的发展。

Abstract: We envision the Full-Body AI Agent as a comprehensive AI system designed to
simulate, analyze, and optimize the dynamic processes of the human body across
multiple biological levels. By integrating computational models, machine
learning tools, and experimental platforms, this system aims to replicate and
predict both physiological and pathological processes, ranging from molecules
and cells to tissues, organs, and entire body systems. Central to the Full-Body
AI Agent is its emphasis on integration and coordination across these
biological levels, enabling analysis of how molecular changes influence
cellular behaviors, tissue responses, organ function, and systemic outcomes.
With a focus on biological functionality, the system is designed to advance the
understanding of disease mechanisms, support the development of therapeutic
interventions, and enhance personalized medicine. We propose two specialized
implementations to demonstrate the utility of this framework: (1) the
metastasis AI Agent, a multi-scale metastasis scoring system that characterizes
tumor progression across the initiation, dissemination, and colonization phases
by integrating molecular, cellular, and systemic signals; and (2) the drug AI
Agent, a system-level drug development paradigm in which a drug AI-Agent
dynamically guides preclinical evaluations, including organoids and chip-based
models, by providing full-body physiological constraints. This approach enables
the predictive modeling of long-term efficacy and toxicity beyond what
localized models alone can achieve. These two agents illustrate the potential
of Full-Body AI Agent to address complex biomedical challenges through
multi-level integration and cross-scale reasoning.

</details>


<div id='physics.bio-ph'></div>

# physics.bio-ph [[Back]](#toc)

### [4] [Single-molecule biophysics](https://arxiv.org/abs/2508.19829)
*Mark C Leake*

Main category: physics.bio-ph

TL;DR: 该论文探讨了单分子生物物理学领域的基础和新兴方法，与传统方法不同，这些方法能够检测和操控单个分子，揭示生物分子异质性及其对分子动力学和相互作用的影响。论文还讨论了技术创新如何推动生理学问题的研究，并启发了受生物系统启发的人工物质设计。


<details>
  <summary>Details</summary>
Motivation: 研究生物分子如何利用自由能产生力和运动，以及单分子生物物理学如何揭示传统方法无法观测的分子异质性和动力学行为。

Method: 采用单分子生物物理学的方法，包括检测和操控单个分子的技术，结合实验测量与理论和计算模拟。

Result: 技术创新和单分子方法为生理学问题提供了深入见解，并启发了生物启发的人工物质设计。

Conclusion: 通过单分子生物物理学的研究，不仅推动了生物物理学的发展，还为新的物理学框架提供了生物学基础的启示。

Abstract: Biological molecules, like all active matter, use free energy to generate
force and motion which drive them out of thermal equilibrium, and undergo
inherent dynamic interconversion between metastable free energy states
separated by levels barely higher than stochastic thermal energy fluctuations.
Here, we explore the founding and emerging approaches of the field of
single-molecule biophysics which, unlike traditional ensemble average
approaches, enable the detection and manipulation of individual molecules and
facilitate exploration of biomolecular heterogeneity and its impact on
transitional molecular kinetics and underpinning molecular interactions. We
discuss the ground-breaking technological innovations which scratch far beyond
the surface into open questions of real physiology, that correlate orthogonal
data types and interplay empirical measurement with theoretical and
computational insights, many of which are enabling artificial matter to be
designed inspired by biological systems. And finally, we examine how these
insights are helping to develop new physics framed around biology.

</details>
